# NEWMONT Corp: financial statements, quarterly

NEM · NYSE · CIK 1164727 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nem.md) · [Financials](/companies/nem/financials.md) · [Filings](/companies/nem/filings.md) · [Insiders](/companies/nem/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nem/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,957 d](/filings/0001164727-26-000010.md) | [4,023](/filings/0001164727-25-000020.md) | [4,402](/filings/0001164727-25-000035.md) | [4,605](/filings/0001164727-25-000046.md) | [5,652 d](/filings/0001164727-26-000010.md) | [5,010](/filings/0001164727-26-000019.md) | [5,317](/filings/0001164727-26-000036.md) | [5,524](/filings/0001164727-26-000043.md) | [6,818 d](/filings/0001164727-26-000010.md) | [7,307](/filings/0001164727-26-000019.md) | [6,118](/filings/0001164727-26-000036.md) | [6,363](/filings/0001164727-26-000043.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [68.0 d](/filings/0001164727-26-000010.md) | [53.0](/filings/0001164727-25-000020.md) | [49.0](/filings/0001164727-25-000035.md) | [47.0](/filings/0001164727-25-000046.md) | [48.0 d](/filings/0001164727-26-000010.md) | [43.0](/filings/0001164727-26-000019.md) | [40.0](/filings/0001164727-26-000036.md) | [40.0](/filings/0001164727-26-000043.md) | [43.0 d](/filings/0001164727-26-000010.md) | [45.0](/filings/0001164727-26-000019.md) | [47.0](/filings/0001164727-26-000036.md) | [58.0](/filings/0001164727-26-000043.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [77.0 d](/filings/0001164727-26-000010.md) | [260](/filings/0001164727-25-000020.md) | [191](/filings/0001164727-25-000035.md) | [244](/filings/0001164727-25-000046.md) | [702 d](/filings/0001164727-26-000010.md) | [647](/filings/0001164727-26-000019.md) | [1,092](/filings/0001164727-26-000036.md) | [787](/filings/0001164727-26-000043.md) | [2,070 d](/filings/0001164727-26-000010.md) | [1,404](/filings/0001164727-26-000019.md) | [952](/filings/0001164727-26-000036.md) | [839](/filings/0001164727-26-000043.md) |
| Net income | $m | [(3,158) d](/filings/0001164727-26-000010.md) | [170](/filings/0001164727-25-000020.md) | [853](/filings/0001164727-25-000035.md) | [922](/filings/0001164727-25-000046.md) | [1,403 d](/filings/0001164727-26-000010.md) | [1,891](/filings/0001164727-26-000019.md) | [2,061](/filings/0001164727-26-000036.md) | [1,832](/filings/0001164727-26-000043.md) | [1,301 d](/filings/0001164727-26-000010.md) | [3,262](/filings/0001164727-26-000019.md) | [2,202](/filings/0001164727-26-000036.md) | [2,475](/filings/0001164727-26-000043.md) |
| Diluted EPS | $ per share | not reported | [0.15](/filings/0001164727-25-000020.md) | [0.74](/filings/0001164727-25-000035.md) | [0.80](/filings/0001164727-25-000046.md) | not reported | [1.68](/filings/0001164727-26-000019.md) | [1.85](/filings/0001164727-26-000036.md) | [1.67](/filings/0001164727-26-000043.md) | not reported | [3.00](/filings/0001164727-26-000019.md) | [2.06](/filings/0001164727-26-000036.md) | [2.35](/filings/0001164727-26-000043.md) |
| Basic EPS | $ per share | not reported | [0.15](/filings/0001164727-25-000020.md) | [0.74](/filings/0001164727-25-000035.md) | [0.80](/filings/0001164727-25-000046.md) | not reported | [1.68](/filings/0001164727-26-000019.md) | [1.86](/filings/0001164727-26-000036.md) | [1.67](/filings/0001164727-26-000043.md) | not reported | [3.01](/filings/0001164727-26-000019.md) | [2.07](/filings/0001164727-26-000036.md) | [2.36](/filings/0001164727-26-000043.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.0](/filings/0001164727-26-000010.md) | [2.3](/filings/0001164727-25-000020.md) | [2.6](/filings/0001164727-25-000035.md) | [3.0](/filings/0001164727-25-000046.md) | [3.6](/filings/0001164727-26-000010.md) | [4.7](/filings/0001164727-26-000019.md) | [6.2](/filings/0001164727-26-000036.md) | [5.6](/filings/0001164727-26-000043.md) | [7.6](/filings/0001164727-26-000043.md) | [8.8](/filings/0001164727-26-000019.md) | [9.0](/filings/0001164727-26-000036.md) | [8.8](/filings/0001164727-26-000043.md) |
| Current assets | $bn | [7.5](/filings/0001164727-25-000011.md) | [11.8](/filings/0001164727-24-000031.md) | [12.1](/filings/0001164727-24-000039.md) | [12.6](/filings/0001164727-24-000061.md) | [12.3](/filings/0001164727-26-000010.md) | [10.7](/filings/0001164727-25-000020.md) | [10.4](/filings/0001164727-25-000035.md) | [10.4](/filings/0001164727-25-000046.md) | [13.1](/filings/0001164727-26-000043.md) | [13.5](/filings/0001164727-26-000019.md) | [13.3](/filings/0001164727-26-000036.md) | [13.6](/filings/0001164727-26-000043.md) |
| Total assets | $bn | [55.5](/filings/0001164727-26-000010.md) | [55.3](/filings/0001164727-25-000020.md) | [55.7](/filings/0001164727-25-000035.md) | [56.2](/filings/0001164727-25-000046.md) | [56.3](/filings/0001164727-26-000010.md) | [55.5](/filings/0001164727-26-000019.md) | [55.2](/filings/0001164727-26-000036.md) | [54.7](/filings/0001164727-26-000043.md) | [57.1](/filings/0001164727-26-000043.md) | [57.7](/filings/0001164727-26-000019.md) | [57.6](/filings/0001164727-26-000036.md) | [58.2](/filings/0001164727-26-000043.md) |
| Current liabilities | $bn | [6.0](/filings/0001164727-25-000011.md) | [5.5](/filings/0001164727-24-000031.md) | [5.7](/filings/0001164727-24-000039.md) | [6.4](/filings/0001164727-24-000061.md) | [7.5](/filings/0001164727-26-000010.md) | [5.4](/filings/0001164727-25-000020.md) | [4.7](/filings/0001164727-25-000035.md) | [5.1](/filings/0001164727-25-000046.md) | [5.7](/filings/0001164727-26-000043.md) | [5.5](/filings/0001164727-26-000019.md) | [5.2](/filings/0001164727-26-000036.md) | [5.5](/filings/0001164727-26-000043.md) |
| Total liabilities | $bn | [26.3](/filings/0001164727-25-000011.md) | [26.3](/filings/0001164727-24-000031.md) | [26.1](/filings/0001164727-24-000039.md) | [26.3](/filings/0001164727-24-000061.md) | [26.2](/filings/0001164727-26-000010.md) | [24.1](/filings/0001164727-25-000020.md) | [22.9](/filings/0001164727-25-000035.md) | [21.3](/filings/0001164727-25-000046.md) | [23.1](/filings/0001164727-26-000043.md) | [22.6](/filings/0001164727-26-000019.md) | [22.2](/filings/0001164727-26-000036.md) | [22.3](/filings/0001164727-26-000043.md) |
| Long-term debt | $bn | [7.0](/filings/0001164727-25-000011.md) | [8.9](/filings/0001164727-24-000031.md) | [8.7](/filings/0001164727-24-000039.md) | [8.6](/filings/0001164727-24-000061.md) | [7.6](/filings/0001164727-26-000010.md) | [7.5](/filings/0001164727-25-000020.md) | [7.1](/filings/0001164727-25-000035.md) | [5.2](/filings/0001164727-25-000046.md) | [5.1](/filings/0001164727-26-000043.md) | [5.1](/filings/0001164727-26-000019.md) | [5.1](/filings/0001164727-26-000036.md) | [5.1](/filings/0001164727-26-000043.md) |
| Current portion of debt | $bn | [1.9](/filings/0001164727-25-000011.md) | [0.0](/filings/0001164727-24-000031.md) | [0.0](/filings/0001164727-24-000039.md) | [0.0](/filings/0001164727-24-000061.md) | [0.9](/filings/0001164727-26-000010.md) | [0.0](/filings/0001164727-25-000020.md) | [0.0](/filings/0001164727-25-000035.md) | [0.0](/filings/0001164727-25-000046.md) | [0.0](/filings/0001164727-26-000010.md) | not reported | not reported | not reported |
| Shareholders' equity | $bn | [29.0](/filings/0001164727-25-000011.md) | [28.9](/filings/0001164727-24-000031.md) | [29.4](/filings/0001164727-24-000039.md) | [29.7](/filings/0001164727-24-000061.md) | [29.9](/filings/0001164727-26-000010.md) | [31.2](/filings/0001164727-25-000020.md) | [32.1](/filings/0001164727-25-000035.md) | [33.2](/filings/0001164727-25-000046.md) | [33.9](/filings/0001164727-26-000043.md) | [34.9](/filings/0001164727-26-000019.md) | [35.2](/filings/0001164727-26-000036.md) | [35.7](/filings/0001164727-26-000043.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [616 d](/filings/0001164727-26-000010.md) | [776](/filings/0001164727-25-000020.md) | [1,428 d](/filings/0001164727-25-000035.md) | [1,648 d](/filings/0001164727-25-000046.md) | [2,511 d](/filings/0001164727-26-000010.md) | [2,031](/filings/0001164727-26-000019.md) | [2,384 d](/filings/0001164727-26-000036.md) | [2,298 d](/filings/0001164727-26-000043.md) | [3,621 d](/filings/0001164727-26-000010.md) | [3,785](/filings/0001164727-26-000019.md) | [2,924 d](/filings/0001164727-26-000036.md) | [2,768 d](/filings/0001164727-26-000043.md) |
| Capital expenditure | $m | [920 d](/filings/0001164727-26-000010.md) | [850](/filings/0001164727-25-000020.md) | [800](/filings/0001164727-25-000035.md) | [877](/filings/0001164727-25-000046.md) | [875 d](/filings/0001164727-26-000010.md) | [826](/filings/0001164727-26-000019.md) | [674](/filings/0001164727-26-000036.md) | [727](/filings/0001164727-26-000043.md) | [808 d](/filings/0001164727-26-000010.md) | [641](/filings/0001164727-26-000019.md) | [719](/filings/0001164727-26-000036.md) | [856](/filings/0001164727-26-000043.md) |
| Dividends paid | $m | [461 d](/filings/0001164727-26-000010.md) | [288](/filings/0001164727-25-000020.md) | [289 d](/filings/0001164727-25-000035.md) | [286 d](/filings/0001164727-25-000046.md) | [282 d](/filings/0001164727-26-000010.md) | [282](/filings/0001164727-26-000019.md) | [279 d](/filings/0001164727-26-000036.md) | [273 d](/filings/0001164727-26-000043.md) | [272 d](/filings/0001164727-26-000010.md) | [282](/filings/0001164727-26-000019.md) | [277 d](/filings/0001164727-26-000036.md) | [272 d](/filings/0001164727-26-000043.md) |
| Share repurchases | $m | [0.0 d](/filings/0001164727-26-000010.md) | [0.0](/filings/0001164727-25-000020.md) | [104 d](/filings/0001164727-25-000035.md) | [344 d](/filings/0001164727-25-000046.md) | [798 d](/filings/0001164727-26-000010.md) | [348](/filings/0001164727-26-000019.md) | [1,011 d](/filings/0001164727-26-000036.md) | [516 d](/filings/0001164727-26-000043.md) | [428 d](/filings/0001164727-26-000010.md) | [1,895](/filings/0001164727-26-000019.md) | [1,567 d](/filings/0001164727-26-000036.md) | [1,779 d](/filings/0001164727-26-000043.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [795](/filings/0001164727-24-000031.md) | [795](/filings/0001164727-24-000039.md) | [796](/filings/0001164727-24-000061.md) | [1,153](/filings/0001164727-25-000020.md) | [1,155](/filings/0001164727-25-000035.md) | [1,149](/filings/0001164727-25-000046.md) | [1,127](/filings/0001164727-26-000019.md) | [1,112](/filings/0001164727-26-000036.md) | [1,100](/filings/0001164727-26-000043.md) | [1,087](/filings/0001164727-26-000019.md) | [1,067](/filings/0001164727-26-000036.md) | [1,051](/filings/0001164727-26-000043.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,039,193,185 at 2026-10-15, from the cover of the [10-Q filed 2026-10-22](/filings/0001164727-26-000043.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.